Your session is about to expire
← Back to Search
BRB Lozenges for Oral Cancer Prevention in Smokers
Study Summary
This trial is testing whether black raspberry lozenges can reduce damage from cigarette smoke in the mouths of adult smokers.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can attend all visits and respond to contacts for 14 weeks.I have not taken high dose antioxidant supplements in the last month.I am not currently pregnant or nursing.I have been smoking at least 5 cigarettes daily for the past year.I haven't had any major health issues like a heart attack or severe asthma in the last 3 months.You haven't seriously tried to quit smoking in the past month and do not plan on quitting for the next four months.I am between 21 and 75 years old.I am currently taking antibiotics.I haven't tried to quit smoking seriously or used any stop-smoking aids in the last month.I haven't seriously tried to quit smoking in the last month and don't plan to in the next 4 months.I understand the study and agree to participate.I can attend all required study visits.I have been smoking at least 5 cigarettes daily for the past year.
- Group 1: BRB Lozenges
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this medical study currently recruiting participants?
"As reported on clinicaltrials.gov, this medical trial is actively recruiting participants. The study was initiated on October 7th 2021 and last updated November 29th 2022."
How many subjects are actively contributing to this clinical experiment?
"Affirmative, the clinicaltrials.gov website clearly states that this research project is currently open for enrollment. This trial was initially published on October 7th 2021 and recently amended on November 29th 2022. In total, 58 patients are needed to be registered at a single institution."
Am I eligible to become a participant in this trial?
"This clinical trial is targeting 58 participants aged 21-75 with evidence of DNA damage. The eligibility criteria includes smoking at least 5 cigarettes/day for 12 months or more, an expired air carbon monoxide measurement >6 parts per million, no serious attempts to quit in the past month and not intending to do so within 4 months from recruitment date, being able to read and write in English, understand and give consent for study procedures, attend all visits during the 14 week period and respond appropriately to research contact between them."
Does your trial take into account those over 45 years of age?
"Per the information published on this clinical trial, potential candidates must be in between 21 to 75 years old. For those who are below 18 or over 65, there is a special selection of 8 and 145 studies respectively."
Who else is applying?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger